Harrison Ford and Michael J. Fox share a profound connection forged through their work together on Season 3 of the Apple TV series Shrinking. The show features Fox, 64, portraying a patient with Parkinson’s disease, who develops a friendship with Ford’s character, Dr. Paul Rhoades, also living with the neurodegenerative condition. This collaboration marks a significant moment as both actors bring their experiences and interpretations of Parkinson’s to the screen, with the focus keyword Harrison Ford Parkinson’s portrayal emphasized in their performances.
Fox, diagnosed with Parkinson’s in 1991, expressed deep admiration for Ford’s ability to embody the disease so authentically. Speaking in a joint interview with Vanity Fair, he revealed the challenge Ford faced in convincingly portraying Parkinson’s despite not having the illness himself.
“That’s one thing that’s amazing about Harrison. I don’t have to convince him I have Parkinson’s, but he had to convince me he had Parkinson’s,”
Fox said.
Ford, 83, responded with respect and gratitude for Fox’s support and openness throughout the filming process.
Ford’s Authentic Representation of Parkinson’s Disease
Michael J. Fox detailed how surprised he was by the depth of Ford’s understanding and nuanced performance. He noted that Ford’s portrayal captured the subtle manifestations of the disease, especially through his eyes and physical expression.
“What I wasn’t prepared for was how much of his own understanding of the disease he brought to it,”
Fox remarked.
“I mean, I recognized Parkinson’s in his eyes. The things I was feeling, I recognized in the way he was expressing himself.”
Fox was so moved by Ford’s acting that it brought him to tears.
“I was just brought to tears by it.”
Ford praised Fox in return, highlighting not only his generosity and support but also his exceptional acting skills.
“[He is] generous, supportive, open, just a wonderful person,”
Ford said of Fox.
“And pretty goddamn good actor too.”
Ford acknowledged the difficulty of portraying Parkinson’s accurately, emphasizing the daunting nature of the disease and the responsibility he felt representing it on screen. He reflected on the variety of experiences his friends with Parkinson’s have had and admired Fox’s extraordinary strength.
“It’s a daunting disease and also a daunting job to represent it in an appropriate way. It was a very important experience for me to have. I have other friends who have Parkinson’s in various degrees and they find themselves in a different condition than Michael is. Michael is an extraordinarily powerful person.”
Michael J. Fox’s Journey with Parkinson’s and Advocacy
Michael J. Fox’s diagnosis came when he was 29 years old, though he did not disclose it publicly until seven years later. Since then, he has become a leading advocate through the Michael J. Fox Foundation for Parkinson’s Research, founded in 2000. This organization has been instrumental in providing support and advancing research for those affected by the disease.
Before returning to acting in Shrinking, Fox’s last role was in a 2020 episode of the CBS drama The Good Fight. That same year, he announced his retirement from professional acting. His involvement in the new season of Shrinking signifies a meaningful return, especially given the personal connection through his character and Ford’s.
Season 3’s Focus on Therapy and Parkinson’s Challenges
Set to premiere on January 28, Shrinking Season 3 will explore Ford’s character, Dr. Paul Rhoades, as he provides therapy to others living with Parkinson’s, including Fox’s character. The series highlights the complex relationship between therapy and managing Parkinson’s symptoms.
“The thing about therapy is it’s a talking cure, but there’s no talking cure for Parkinson’s, so those two worlds have always had an uneasy relationship,”
Fox explained.
“I couldn’t have gotten through Parkinson’s without therapy, but you find yourself educating the therapist as much as they’re educating you. You have to paint a picture of the ground you’re living on. And it’s very hard to explain to people.”
This dynamic sheds light on the emotional and physical aspects of living with Parkinson’s, emphasizing the challenge of conveying invisible symptoms to others, even to trained professionals.
Reuniting with Collaborators and On-Set Experience
Fox’s role reunites him with Bill Lawrence, creator of the series and producer known for prior successful projects. The cast also includes lead actor Jason Segel and recurring star Brett Goldstein.
Fox humorously recounted his conversation with Lawrence about joining the show, expressing his surprise at not being contacted sooner for a project featuring both Ford and Parkinson’s themes.
“It was a short and profane conversation,”
Fox recalled.
“I said, ‘You’re doing a f—ing show about Parkinson’s with Harrison f—ing Ford, and you don’t call me?’”
Fox has shared how working on the set was uplifting and empowering, as he no longer had to worry about the physical challenges usually associated with managing Parkinson’s symptoms during filming.
“It was the first time ever I get to show up on-set, and I didn’t have to worry about am I too tired or coughing or anything,”
he told People.
“I just do it.”
He described his approach to difficult moments in scenes, resolving to adapt when symptoms interfered and pushing through despite challenges.
“It was really good, because for the moments when I say, ‘I’m not going to be able to do this,’ then I say, ‘Well, I’ll just deal with how I can’t do it in the scene.’ And you get through it,”
Fox added.
Implications of Ford and Fox’s Performances on Public Awareness
Harrison Ford’s portrayal of a Parkinson’s patient, combined with Michael J. Fox’s authentic depiction, is expected to deepen public understanding of Parkinson’s disease. By presenting the illness through nuanced characters who share this experience, Shrinking aims to foster empathy and highlight the realities faced by those living with the condition.
The series’ release in early 2026 will likely spark renewed conversations about neurodegenerative diseases, therapy’s role in treatment, and the importance of continued research and advocacy as championed by Fox and the foundation bearing his name.
For audiences and those affected by Parkinson’s alike, the collaboration between these two iconic actors adds a meaningful, human dimension to the portrayal of this complex disease in popular culture.
